Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 19

1.

Scenarios to manage the hepatitis C disease burden and associated economic impact of treatment in Turkey.

Örmeci N, Malhan S, Balık İ, Ergör G, Razavi H, Robbins S.

Hepatol Int. 2017 Nov;11(6):509-516. doi: 10.1007/s12072-017-9820-3. Epub 2017 Oct 12.

PMID:
29027109
2.

Tenofovir-best hope for treatment of chronic hepatitis B infection?

Örmeci N, Özbaş B, Güner R, Özkan H, Yalçı A, Çoban Ş, Dökmeci A, Kalkan Ç, Akıncı H, Yüksel O, Başar Ö, Yüksel İ, Balık İ.

Turk J Gastroenterol. 2015 Jul;26(4):322-7. doi: 10.5152/tjg.2015.0164. Epub 2015 Jun 2.

3.

A Quasi-Experimental Study Analyzing the Effectiveness of Portable High-Efficiency Particulate Absorption Filters in Preventing Infections in Hematology Patients during Construction.

Özen M, Yılmaz G, Coşkun B, Topçuoğlu P, Öztürk B, Gündüz M, Atilla E, Arslan Ö, Özcan M, Demirer T, İlhan O, Konuk N, Balık İ, Gürman G, Akan H.

Turk J Haematol. 2016 Mar 5;33(1):41-7. doi: 10.4274/tjh.2014.0010. Epub 2014 May 21.

4.

Strategies to manage hepatitis C virus (HCV) disease burden.

Wedemeyer H, Duberg AS, Buti M, Rosenberg WM, Frankova S, Esmat G, Örmeci N, Van Vlierberghe H, Gschwantler M, Akarca U, Aleman S, Balık I, Berg T, Bihl F, Bilodeau M, Blasco AJ, Brandão Mello CE, Bruggmann P, Calinas F, Calleja JL, Cheinquer H, Christensen PB, Clausen M, Coelho HS, Cornberg M, Cramp ME, Dore GJ, Doss W, El-Sayed MH, Ergör G, Estes C, Falconer K, Félix J, Ferraz ML, Ferreira PR, García-Samaniego J, Gerstoft J, Giria JA, Gonçales FL Jr, Guimarães Pessôa M, Hézode C, Hindman SJ, Hofer H, Husa P, Idilman R, Kåberg M, Kaita KD, Kautz A, Kaymakoglu S, Krajden M, Krarup H, Laleman W, Lavanchy D, Lázaro P, Marinho RT, Marotta P, Mauss S, Mendes Correa MC, Moreno C, Müllhaupt B, Myers RP, Nemecek V, Øvrehus AL, Parkes J, Peltekian KM, Ramji A, Razavi H, Reis N, Roberts SK, Roudot-Thoraval F, Ryder SD, Sarmento-Castro R, Sarrazin C, Semela D, Sherman M, Shiha GE, Sperl J, Stärkel P, Stauber RE, Thompson AJ, Urbanek P, Van Damme P, van Thiel I, Vandijck D, Vogel W, Waked I, Weis N, Wiegand J, Yosry A, Zekry A, Negro F, Sievert W, Gower E.

J Viral Hepat. 2014 May;21 Suppl 1:60-89. doi: 10.1111/jvh.12249.

PMID:
24713006
5.

The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm.

Razavi H, Waked I, Sarrazin C, Myers RP, Idilman R, Calinas F, Vogel W, Mendes Correa MC, Hézode C, Lázaro P, Akarca U, Aleman S, Balık I, Berg T, Bihl F, Bilodeau M, Blasco AJ, Brandão Mello CE, Bruggmann P, Buti M, Calleja JL, Cheinquer H, Christensen PB, Clausen M, Coelho HS, Cramp ME, Dore GJ, Doss W, Duberg AS, El-Sayed MH, Ergör G, Esmat G, Falconer K, Félix J, Ferraz ML, Ferreira PR, Frankova S, García-Samaniego J, Gerstoft J, Giria JA, Gonçales FL Jr, Gower E, Gschwantler M, Guimarães Pessôa M, Hindman SJ, Hofer H, Husa P, Kåberg M, Kaita KD, Kautz A, Kaymakoglu S, Krajden M, Krarup H, Laleman W, Lavanchy D, Marinho RT, Marotta P, Mauss S, Moreno C, Murphy K, Negro F, Nemecek V, Örmeci N, Øvrehus AL, Parkes J, Pasini K, Peltekian KM, Ramji A, Reis N, Roberts SK, Rosenberg WM, Roudot-Thoraval F, Ryder SD, Sarmento-Castro R, Semela D, Sherman M, Shiha GE, Sievert W, Sperl J, Stärkel P, Stauber RE, Thompson AJ, Urbanek P, Van Damme P, van Thiel I, Van Vlierberghe H, Vandijck D, Wedemeyer H, Weis N, Wiegand J, Yosry A, Zekry A, Cornberg M, Müllhaupt B, Estes C.

J Viral Hepat. 2014 May;21 Suppl 1:34-59. doi: 10.1111/jvh.12248.

PMID:
24713005
6.

Historical epidemiology of hepatitis C virus (HCV) in selected countries.

Bruggmann P, Berg T, Øvrehus AL, Moreno C, Brandão Mello CE, Roudot-Thoraval F, Marinho RT, Sherman M, Ryder SD, Sperl J, Akarca U, Balık I, Bihl F, Bilodeau M, Blasco AJ, Buti M, Calinas F, Calleja JL, Cheinquer H, Christensen PB, Clausen M, Coelho HS, Cornberg M, Cramp ME, Dore GJ, Doss W, Duberg AS, El-Sayed MH, Ergör G, Esmat G, Estes C, Falconer K, Félix J, Ferraz ML, Ferreira PR, Frankova S, García-Samaniego J, Gerstoft J, Giria JA, Gonçales FL Jr, Gower E, Gschwantler M, Guimarães Pessôa M, Hézode C, Hofer H, Husa P, Idilman R, Kåberg M, Kaita KD, Kautz A, Kaymakoglu S, Krajden M, Krarup H, Laleman W, Lavanchy D, Lázaro P, Marotta P, Mauss S, Mendes Correa MC, Müllhaupt B, Myers RP, Negro F, Nemecek V, Örmeci N, Parkes J, Peltekian KM, Ramji A, Razavi H, Reis N, Roberts SK, Rosenberg WM, Sarmento-Castro R, Sarrazin C, Semela D, Shiha GE, Sievert W, Stärkel P, Stauber RE, Thompson AJ, Urbanek P, van Thiel I, Van Vlierberghe H, Vandijck D, Vogel W, Waked I, Wedemeyer H, Weis N, Wiegand J, Yosry A, Zekry A, Van Damme P, Aleman S, Hindman SJ.

J Viral Hepat. 2014 May;21 Suppl 1:5-33. doi: 10.1111/jvh.12247. Review.

PMID:
24713004
7.

The characteristics of patients with chronic hepatitis B in Turkey.

Kemal Celen M, Tekin Koruk S, Aygen B, Dal T, Karabay O, Tosun S, Koksal I, Turgut H, Onlen Y, Balik I, Yildirim N, Sinan Dal M, Ayaz C, Tabak F.

Med Glas (Zenica). 2014 Feb;11(1):94-8.

PMID:
24496347
8.

Surveillance, control and management of infections in intensive care units in Southern Europe, Turkey and Iran--a prospective multicenter point prevalence study.

Erdem H, Inan A, Altındis S, Carevic B, Askarian M, Cottle L, Beovic B, Csomos A, Metodiev K, Ahmetagic S, Harxhi A, Raka L, Grozdanovski K, Nechifor M, Alp E, Bozkurt F, Hosoglu S, Balik I, Yilmaz G, Jereb M, Moradi F, Petrov N, Kaya S, Koksal I, Aslan T, Elaldi N, Akkoyunlu Y, Moravveji SA, Csato G, Szedlak B, Akata F, Oncu S, Grgic S, Cosic G, Stefanov C, Farrokhnia M, Müller M, Luca C, Koluder N, Korten V, Platikanov V, Ivanova P, Soltanipour S, Vakili M, Farahangiz S, Afkhamzadeh A, Beeching N, Ahmed SS, Cami A, Shiraly R, Jazbec A, Mirkovic T, Leblebicioglu H, Naber K.

J Infect. 2014 Feb;68(2):131-40. doi: 10.1016/j.jinf.2013.11.001. Epub 2013 Nov 20.

PMID:
24269951
9.

Pegylated interferon alfa-2B for chronic delta hepatitis: 12 versus 24 months.

Ormeci N, Bölükbaş F, Erden E, Coban S, Ekiz F, Erdem H, Palabıyıkoğlu M, Beyler AR, Balık I, Bölükbaş C, Nazlıgül Y, Köklü S.

Hepatogastroenterology. 2011 Sep-Oct;58(110-111):1648-53. doi: 10.5754/hge10126.

PMID:
22086695
10.

The impact of a nationwide antibiotic restriction program on antibiotic usage and resistance against nosocomial pathogens in Turkey.

Altunsoy A, Aypak C, Azap A, Ergönül Ö, Balık I.

Int J Med Sci. 2011;8(4):339-44. Epub 2011 May 24.

11.

[Prevalence of extrahepatic illnesses in patients with chronic hepatitis b and hepatitis c: retrospective study of 435 patients].

Cesur S, Akin K, Albayrak F, Birengel S, Kurt H, Balik I.

Mikrobiyol Bul. 2003 Apr-Jun;37(2-3):187-93. Turkish.

PMID:
14593902
12.

Tuberculous meningitis in adults in Turkey: epidemiology, diagnosis, clinic and laboratory [corrected].

Hoşoğlu S, Geyik MF, Balik I, Aygen B, Erol S, Aygencel SG, Mert A, Saltoğlu N, Dökmetaş I, Felek S, Sünbül M, Irmak H, Aydin K, Ayaz C, Kökoğlu OF, Uçmak H, Satilmiş S.

Eur J Epidemiol. 2003;18(4):337-43. Erratum in: Eur J Epidemiol. 2003;18(5):463. Sümbül M [corrected to Sünbül M].

PMID:
12803374
13.

[Hepatitis A and hepatitis E seroprevalence in adults in the Ankara area].

Cesur S, Akin K, Doğaroğlu I, Birengel S, Balik I.

Mikrobiyol Bul. 2002 Jan;36(1):79-83. Turkish.

PMID:
12476770
14.

Predictors of outcome in patients with tuberculous meningitis.

Hosoglu S, Geyik MF, Balik I, Aygen B, Erol S, Aygencel TG, Mert A, Saltoglu N, Dokmetas I, Felek S, Sunbul M, Irmak H, Aydin K, Kokoglu OF, Ucmak H, Altindis M, Loeb M.

Int J Tuberc Lung Dis. 2002 Jan;6(1):64-70.

PMID:
11931403
15.

Association of diabetes mellitus and chronic hepatitis C virus infection.

Balik I, Yilmaz N, Turkcapar N, Yasa H.

Hepatology. 1999 Aug;30(2):584. No abstract available.

PMID:
10447386
16.

Widespread detection of PER-1-type extended-spectrum beta-lactamases among nosocomial Acinetobacter and Pseudomonas aeruginosa isolates in Turkey: a nationwide multicenter study.

Vahaboglu H, Oztürk R, Aygün G, Coşkunkan F, Yaman A, Kaygusuz A, Leblebicioglu H, Balik I, Aydin K, Otkun M.

Antimicrob Agents Chemother. 1997 Oct;41(10):2265-9. Erratum in: Antimicrob Agents Chemother 1998 Feb;42(2):484.

17.

Epidemiology and clinical outcome of hepatitis D virus infection in Turkey.

Balik I, Onul M, Tekeli E, Caredda F.

Eur J Epidemiol. 1991 Jan;7(1):48-54.

PMID:
2026223
18.

[75th birthday of Julie Pollaková, M.D].

Balík I.

Cesk Oftalmol. 1975 Jul;31(4):301-2. Czech. No abstract available.

PMID:
1098789
19.

[SERUM CHOLESTEROL AND PHOSPHOLIPIDS IN PATIENTS WITH TAPETORETINAL DEGENERATION].

BALIK I, FABRYOVA D.

Cesk Oftalmol. 1964 May;20:163-5. Czech. No abstract available.

PMID:
14158576

Supplemental Content

Support Center